1 / 5

Global Liposome Drug Delivery Market

The global liposome drug delivery market is expected to reach an estimated value of ~USD 10 billion by 2035, by expanding at a CAGR of ~9%. The market further generated a revenue of ~USD 5 billion in the year 2022.

meghanester
Download Presentation

Global Liposome Drug Delivery Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Liposome Drug Delivery Market 2023-2035SWOT Analysis, Growth at a CAGR of ~9% Global Liposome Drug Delivery Market Key Insights During the forecast period of 2023-2035, the global liposome drug delivery market is expected to reach an estimated value of ~USD 10 billion by 2035, by expanding at a CAGR of ~9%. The market further generated a revenue of ~USD 5 billion in the year 2022. Major key factors propelling the growth of liposome drug delivery market worldwide are the growing prevalence of cancer, and surge in use of liposome as drug delivery system. Market Definition of Liposome Drug Delivery A membrane made of lipid (fat) molecules, typically phospholipids, completely encloses an aqueous volume in vesicles or bags known as liposomes. Liposomes are bilayer vesicles in terms of structure, and their membrane could contain medications that are water soluble. By shattering biological membranes with sonication, liposomes are created. The versatility, biodegradability, hypoallergenic nature, and resemblance to biological membranes of a liposome are crucial considerations in the ongoing development of liposomal drug delivery systems. Multilamellar vesicles, small unilamellar liposome vesicles, large unilamellar vesicles, and cochleate vesicles are the different forms of liposomes. Global Liposome Drug Delivery Market: Growth Drivers The growth of the global liposome drug delivery market can majorly be attributed to the rise in number of cancer patient all across the globe. Targeted therapy for cancer treatment includes the use of liposomal drug delivery in chemotherapy, radiation therapy, and surgical resection. The American Cancer Society estimates that there would be 1.9 million new cases and 0.6 million cancer deaths in the USA in 2021. Lung, prostate, bowel, and female breast cancer account for 43% of all new instances of cancer, making them the four most prevalent cancers worldwide. Therefore, it is projected that during the upcoming years, the market for liposomal drug delivery would have increased demand owing to the increasing incidence rate of cancer worldwide. Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4073

  2. Further, growing obesity among people also estimated to drive the growth of the market. Over 1 billion individuals, including 650 million adults, 340 million teenagers, and 39 million children, are obese worldwide. Additionally, liposomal drug delivery is a great option for patients with a range of chronic conditions since it has better pharmacokinetics and pharmacodynamics, increased therapeutic effectiveness, and lower toxicity. Approximately 6 out of 10 Americans, with 4 out of 10 having two or more chronic diseases, according to the Centers for Disease Control and Prevention (CDC). Over the course of the forecast period, this trend is expected to intensify, supporting the expansion of the liposomal drug delivery market. The global liposome drug delivery market is also estimated to grow majorly on account of the following: •Growing Application of Liposome as Drug Delivery System •Rising Government Initiatives in Research and Development for Cancer Dugs •Surge in Level of Stress Among People Global Liposome Drug Delivery Market: Restraining Factor Throughout the projection period, market growth is anticipated to be constrained by the high cost of liposomal drug delivery. The high price of equipment makes liposomal therapy more expensive and out of reach for patients, which restrains the market's expansion. For instance, according to the Journal of Biotechnology & Biomaterials lipid/liposomal drug delivery systems are expensive to develop, which contributes to their high production cost. The high cost of lipid excipients' raw materials and the need for pricey machinery to enhance production are the causes of the goods' high price. Additionally, the ScienceDirect Journal claims that the most expensive treatment for conditions including psoriasis, atopic dermatitis, and skin cancer is liposomal drug delivery. Request for customization @https://www.researchnester.com/customized-reports-4073 Global Liposome Drug Delivery Market Segmentation •By Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others)

  3. •By Technology (Stealth, Non-PEGylated, and DepoFoam Liposome, Technology) •By Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, Photodynamic Therapy, and Others) The cancer therapy segment is anticipated to hold the largest market share over the forecast period. The growth of this segment can be attributed to growing prevalence of cancer all across the world. One in six deaths, or around 10 million deaths, were caused by cancer in 2020, making it the top cause of mortality worldwide. Uncontrollable cellular proliferation in the body is what causes cancer. Malignant cells are the cancer-causing cells. Cancer can be treated in a variety of ways, including surgery, radiation therapy, chemotherapy, and other approaches. However, this therapy comes with various side effects, which includes hair loss, death of living cells, and more. These side effects thus have decreased the appeal of such medications. Hence, liposomal therapy is helpful in overcoming these issues and side effects in cancer treatment. •By Region The North America liposome drug delivery market is anticipated to hold the largest market share by the end of 2035 among the market in all the other regions, backed by growing prevalence of cancer in the region, followed by the rise in government initiatives that promote research and development for cancer drugs and drug delivery systems, along with the surge in healthcare expenditure in the region. According to data supplied by the National Cancer Institute, new cancer cases were predicted to be detected in the United States in 2020. (NCI). The total was 1806590 cases. The statistics also indicated that 606520 people would die from the ailment in the same year. Obtain this Report @ https://www.researchnester.com/reports/liposome-drug-delivery- market/4073 The market research report on global liposome drug delivery also includes the market size, market revenue, Y-o-Y growth, and key player analysis applicable for the market in North America (U.S., and Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands &

  4. Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), and Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa). Key Market Players Featured in the Global Liposome Drug Delivery Market Some of the key players of the global liposome drug delivery market are Spectrum Pharmaceuticals, Inc., Gilead Sciences, Inc., Celsion Corporation, Ipsen Pharma, Pacira Pharmaceuticals, Inc., Novartis AG, CordenPharma International, FUJIFILM Toyama Chemical Co., Ltd., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., Astellas Pharma Inc., Elan Pharmaceuticals (Perrigo Company plc), Merrimack Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., and others. Besides this, some of the prominent raw material manufacturers in the global liposome drug delivery market that are included in our report are NIPPON FINE CHEMICAL CO., LTD., Sonic Biochem Extractions Pvt. Ltd., Croda International Plc, Lipoid GmbH, Hashimoto Electronic Industry Co., LTD, and others. About Research Nester Research Nester, which is a leading service provider for strategic market research and consulting services, aims to provide unbiased, unparalleled market insights and industry analysis. These analyses help conglomerates, executives, and industries to take wise decisions for their businesses as well as for their future marketing strategy, expansion and investment among others. We believe that our expertise in the field of market research can help businesses to expand to its new horizon. Our team of research analysts can provide businesses a right guidance at the right time, while our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919

More Related